Fly News Breaks for March 10, 2016
AMED
Mar 10, 2016 | 09:15 EDT
Oppenheimer analyst Michael Wiederhorn raised his price target for Amedisys to $45 from $40 given the improved operational outlook and the strong growth prospects for the company across its various business lines. The analyst reiterates his Outperform rating on the stock.
News For AMED From the Last 2 Days